What is Eli Lilly's change in receivables?

Eli Lilly (LLY) reported change in receivables of $1.75B in Q4 2025.

How has Eli Lilly's change in receivables changed year-over-year?

Eli Lilly's change in receivables increased by 224.8% year-over-year, from $538.75M to $1.75B.

What is the long-term trend for Eli Lilly's change in receivables?

Over 4 years (2021 to 2025), Eli Lilly's change in receivables has grown at a 53.0% compound annual growth rate (CAGR), from $1.28B to $7B.

What does change in receivables mean?

Change in total receivables including trade and non-trade receivables.

Eli Lilly LLY Change in receivables

Change in receivables at other companies

Cardinal HealthCAH

$17M-85.1%

McKessonMCK

$207M-85.2%

Other financials

Income statement

See full

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

See full

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

See full

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

See full

Market cap$1.07T+51.7%

Enterprise value$1.11T+49.3%

P/E42.3×-8.8×

P/S14.8×+1.6×

Profitability

See full

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

See full

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables.

The official record: Eli Lilly’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eli Lilly's change in receivables?: Eli Lilly (LLY) reported change in receivables of $1.75B in Q4 2025.
How has Eli Lilly's change in receivables changed year-over-year?: Eli Lilly's change in receivables increased by 224.8% year-over-year, from $538.75M to $1.75B.
What is the long-term trend for Eli Lilly's change in receivables?: Over 4 years (2021 to 2025), Eli Lilly's change in receivables has grown at a 53.0% compound annual growth rate (CAGR), from $1.28B to $7B.
What does change in receivables mean?: Change in total receivables including trade and non-trade receivables.